Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1
Top Cited Papers
Open Access
- 1 March 2012
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 188 (5), 2127-2135
- https://doi.org/10.4049/jimmunol.1102412
Abstract
It is estimated that 1 billion people around the world are vitamin D deficient. Vitamin D deficiency has been linked to various inflammatory diseases. However, the mechanism by which vitamin D reduces inflammation remains poorly understood. In this study, we investigated the inhibitory effects of physiologic levels of vitamin D on LPS-stimulated inflammatory response in human blood monocytes and explored potential mechanisms of vitamin D action. We observed that two forms of the vitamin D, 1,25(OH)2D3, and 25(OH)D3, dose dependently inhibited LPS-induced p38 phosphorylation at physiologic concentrations, IL-6 and TNF-α production by human monocytes. Upon vitamin D treatment, the expression of MAPK phosphatase-1 (MKP-1) was significantly upregulated in human monocytes and murine bone marrow-derived macrophages (BMM). Increased binding of the vitamin D receptor and increased histone H4 acetylation at the identified vitamin D response element of the murine and human MKP-1 promoters were demonstrated. Moreover, in BMM from MKP1−/− mice, the inhibition of LPS-induced p38 phosphorylation by vitamin D was completely abolished. Vitamin D inhibition of LPS-induced IL-6 and TNF-α production by BMM from MKP-1−/− mice was significantly reduced as compared with wild-type mice. In conclusion, this study identified the upregulation of MKP-1 by vitamin D as a novel pathway by which vitamin D inhibits LPS-induced p38 activation and cytokine production in monocytes/macrophages.Keywords
This publication has 51 references indexed in Scilit:
- MicroRNA-101 Targets MAPK Phosphatase-1 To Regulate the Activation of MAPKs in MacrophagesPublished by The American Association of Immunologists ,2010
- A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolutionGenome Research, 2010
- Vitamin D: newly discovered actions require reconsideration of physiologic requirementsTrends in Endocrinology & Metabolism, 2010
- A Downstream Intergenic Cluster of Regulatory Enhancers Contributes to the Induction of CYP24A1 Expression by 1α,25-Dihydroxyvitamin D3Published by Elsevier BV ,2010
- Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid useJournal of Allergy and Clinical Immunology, 2010
- Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor DephosphorylationPublished by Elsevier BV ,2009
- Inflammation and cancer: Role of nuclear factor‐kappaB activationCancer Science, 2008
- Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunityNature Clinical Practice Endocrinology & Metabolism, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1The Journal of Experimental Medicine, 2006